Profile

Perry Shen, M.D.Wake Forest Baptist Health

Doctor Rating

4.7 out of 5

190 Ratings
18 Comments
 

Perry Shen, M.D.

Program Director,
Professor,

Clinical Interests

Gastrointestinal Oncology Surgery, Hepatobiliary Surgery, Melanoma, Minimally Invasive Liver and Pancreatic Resection, Pancreatic Surgery, Peritoneal Surface Malignancies, Sarcoma

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-4276
Department: 336-716-0545

Email: pshen@wakehealth.edu

Insurance Accepted »

Media Medical Expert »

Education & Training

  • B.A., University of California-Irvine, 1988
  • B.S., University of California-Irvine, 1988
  • M.D., University of Southern California Sch of Medicine, 1992
  • Internship, Obstetrics & Gynecology, J Hopkins-Balti Cty Hosps, 1993
  • Residency, Surgery, U Southern Calif Affil Hosps, 1998
  • Fellowship, John Wayne Cancer Institute, 2000

Board Certifications

  • American Board of Surgery, Surgery

Memberships

  • Am Assn Of Cancer Research
  • Am Coll Of Surgeons
  • Am Hepato-Pancreato-Biliary
  • Am Medical Assn
  • Am Soc of Clinical Oncology
  • Assn Of Academic Surgery
  • Forsyth-Davie-Stokes Medical S
  • North Carolina Medical Assn
  • North Carolina Surgical Assn
  • Soc Of Surgical Oncology
  • Soc for Sur Of Alimentary Trac
  • Society of Graduate Surgeons
  • Southeastern Surgical Congress
  • Southern Surgical Society

NPI Number

  • 1417932575
Perry Shen, M.D.

Doctor Rating

4.7 out of 5

190 Ratings
18 Comments
 

Perry Shen, M.D.

Program Director, Surgical Oncology
Professor, General Surgery
Comprehensive Cancer Center

Research Interests

cancer/oncogenesis

Contact Information

Academic: 336-716-0545 | Department: 336-716-0545

Email: pshen@wakehealth.edu

Media Medical Expert »

Recent Publications

Doud AN, Levine EA, Fino NF, Stewart JH, Shen P, Votanopoulos KI. Stoma creation and reversal after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2016;23(2):503-510.

Mogal HD, Levine EA, Russell G, Shen P, Stewart JH, Votanopoulos KI. Conditional survival after cytoreductive surgery with heated intraperitoneal chemotherapy for low- and high-grade appendiceal primaries. Ann Surg Oncol. 2016;23(2):534-538.

Amini N, Kim Y, Wilson A, Georgios GA, Ethun CG, Maithel SK, Poultsides GA, Tran T, Idrees K, Isom CA, Fields RC, Krasnick BA, Weber S, Salem AI, Martin RC, Scoggins C, Shen P, Mogal H, Schmidt CR, Beal EW, Hatzaras I, Shenoy R, Pawlik TM. Optimal prognostic lymph node staging system for gallbladder adenocarcinoma: a multi-institutional study [abstract]. Ann Surg Oncol. 2016;23(Suppl 1):S12.

Buettner S, Margonis G, Kim Y, Ethun CG, Maithel SK, Poultsides GA, Tran T, Idrees K, Isom CA, Fields RC, Krasnick BA, Weber S, Salem AI, Martin RC, Scoggins C, Shen P, Mogal H, Schmidt CR, Beal EW, Hatzaras I, Shenoy R, Pawlik TM. Conditional survival probability of long-term survival after resection of hilar cholangiocarcinoma [abstract]. Ann Surg Oncol. 2016;23(Suppl 1):S107.

Davidson JT, Jin L, Krasnick BA, Ethun CG, Pawlik TM, Poultsides GA, Tran TB, Idress K, Isom CA, Weber S, Salem AI, Hawkins W, Strasberg S, Martin RC, Scoggins C, Shen P, Mogal H, Schmidt CR, Beal EW, Hatzaras I, Shenoy R, Maithel SK, Fields RC. A reappraisal of staging laparoscopy in three subtypes of cholangiocarcinoma: a multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium [abstract]. Ann Surg Oncol. 2016;23(Suppl 1):S9.

Ethun CG, Postlewait LM, Le N, Pawlik TM, Buettner S, Poultsides GA, Tran T, Idrees K, Isom CA, Fields RC, Jin L, Weber S, Salem AI, Martin RC, Scoggins C, Shen P, Mogal H, Schmidt CR, Beal EW, Hatzaras I, Shenoy R, Cardona K, Maithel SK. A novel pathology-based preoperative risk score to predict distant and locoregional residual disease and survival for incidentally discovered gallbladder cancer: a 10-institution study from the US Extrahepatic Biliary Malignancy Consortium [abstract]. Ann Surg Oncol. 2016;23(Suppl 1):S11.

Ethun CG, Postlewait LM, Le N, Pawlik TM, Buettner S, Poultsides GA, Tran T, Idrees K, Isom CA, Fields RC, Jin L, Weber S, Salem AI, Martin RC, Scoggins C, Shen P, Mogal H, Schmidt CR, Beal EW, Hatzaras I, Vitiello G, Kooby DA, Maithel SK. The optimal time-interval to re-resection for incidentally discovered gallbladder cancer: a multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium [abstract]. Ann Surg Oncol. 2016;23(Suppl 1):S104.

Jin L, Krasnick BA, Davidson JT, Ethun CG, Pawlik TM, Poultsides GA, Tran TB, Idrees K, Isom CA, Weber S, Salem AI, Hawkins W, Strasberg S, Martin RC, Scoggins C, Shen P, Mogal H, Schmidt CR, Beal EW, Hatzaras I, Shenoy R, Maithel SK, Fields RC. The effect of postoperative morbidity on long-term survival after curative resection for extrahepatic biliary tumors: a multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium [abstract]. Ann Surg Oncol. 2016;23(Suppl 1):S117.

Kim Y, Amini N, Georgios GA, Wilson A, Ethun CG, Poultsides GA, Tran T, Idrees K, Isom CA, Fields RC, Krasnick BA, Weber S, Salem AI, Martin RC, Scoggins C, Shen P, Mogal H, Schmidt CR, Beal EW, Hatzaras I, Shenoy R, Cardona K, Maithel SK, Pawlik TM. Impact of chemotherapy and external-beam radiation therapy on outcomes among patients with resected gallbladder cancer: a multi-institutional analysis [abstract]. Ann Surg Oncol. 2016;23(Suppl 1):S12.

Krasnick BA, Jin L, Davidson JT, Ethun CG, Pawlik TM, Poultsides GA, Tran T, Idrees K, Isom CA, Weber S, Salem AI, Hawkins W, Strasberg S, Martin RC, Scoggins C, Shen P, Mogal H, Schmidt CR, Beal EW, Hatzaras I, Shenoy R, Maithel SK, Fields RC. Curative resection for hilar cholangiocarcinoma: does adjuvant therapy impact overall survival? A multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium [abstract]. Ann Surg Oncol. 2016;23(Suppl 1):S113.

Mogal H, Dodson R, Fino N, Ethun CG, Pawlik TM, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Jin L, Weber S, Salem AI, Martin RC, Scoggins C, Schmidt CR, Beal EW, Hatzaras I, Shenoy R, Maithel SK, Shen P. Effect of preoperative bilirubin on outcomes of completely resected hilar cholangiocarcinoma: a multi-institutional analysis [abstract]. Ann Surg Oncol. 2016;23(Suppl 1):S113.

Mogal H, O'Connor S, Fino N, Ethun CG, Pawlik TM, Poultsides GA, Tran TB, Idrees K, Isom CA, Fields RC, Jin L, Weber S, Salem AI, Martin RC, Scoggins C, Schmidt CR, Beal EW, Hatzaras I, Shenoy R, Maithel SK, Shen P. Rates and patterns of recurrence following complete resection of hilar cholangiocarcinoma: results from the US Extrahepatic Biliary Consortium [abstract]. Ann Surg Oncol. 2016;23(Suppl 1):S108.

Tran TB, Norton JA, Ethun CG, Pawlik TM, Buettner S, Idrees K, Isom CA, Fields RC, Krasnick BA, Weber S, Salem AI, Martin RC, Scoggins C, Shen P, Mogal H, Schmidt CR, Beal EW, Hatzaras I, Shenoy R, Maithel SK, Poultsides GA. Gallbladder cancer presenting with jaundice: uniformly fatal or still potentially curable? [abstract]. Ann Surg Oncol. 2016;23(Suppl 1):S116-S117.

Dodson RM, Mogal H, Russell G, Duckworth KE, Votanopoulos K, Shen P, Levine EA, McQuellon RP. Association of survival, postoperative morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy using quality of life assessments [abstract]. Ann Surg Oncol. 2016;23(Suppl 1):S35.

Levine EA, Votanopoulos KI, Qasem SA, Philip J, Cummins KA, Chou JW, Ruiz J, D'Agostino R, Shen P, Miller LD. Prognostic molecular subtypes of low-grade cancer of the appendix. J Am Coll Surg. 2016;222(4):493-503.

Mogal H, Chouliaras K, Levine EA, Shen P, Votanopoulos KI. Repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: review of indications and outcomes. J Gastrointest Oncol. 2016;7(1):129-142.

Cummins KA, Russell GB, Votanopoulos KI, Shen P, Stewart JH, Levine EA. Peritoneal dissemination from high-grade appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). J Gastrointest Oncol. 2016;7(1):3-9.

Doud AN, Randle RW, Clark CJ, Levine EA, Swett KR, Shen P, Stewart JH, Votanopoulos KI. Impact of distal pancreatectomy on outcomes of peritoneal surface disease treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2015;22(5):1645-1650.

Randle RW, Doud AN, Levine EA, Clark CJ, Swett KR, Shen P, Stewart JH, Votanopoulos KI. Peritoneal surface disease with synchronous hepatic involvement treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2015;22(5):1634-1638.

Votanopoulos KI, Russell G, Randle RW, Shen P, Stewart JH, Levine EA. Peritoneal surface disease (PSD) from appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): overview of 481 cases. Ann Surg Oncol. 2015;22(4):1274-1279.

Randle RW, Ahmed S, Levine EA, Fino NF, Swett KR, Stewart JH, Shen P, Votanopoulos KI. Significance of diabetes on morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2015;111(6):740-745.

Randle RW, Griffith KF, Fino NF, Swett KR, Stewart JH IV, Shen P, Levine EA, Votanopoulos KI. Appendiceal goblet cell carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Res. 2015;196(2):229-234.

Slocum K, Adams L, Shen P, Griffith K, Allen S, Fino N, DeRoche A. Thoracic epidural versus intravenous patient controlled analgesia in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy [abstract]. In: Abstracts of the 14th Annual ASRA Pain Medicine Meeting; 2015 May 14-16; Las Vegas (NV). 2015;():A530.

Randle RW, Qasem SA, Shen P. Biliary duplication cyst. Am Surg. 2015;81(7):E291-E293.

Mogal H, Fino N, Clark CJ, Shen P. Comparison of observed to predicted outcomes using the ACS NSQIP universal risk calculator in patients undergoing pancreatoduodenectomy [abstract]. Ann Surg Oncol. 2015;22(Suppl 1):S133.

Shen P, Fino N, Levine EA, Eversole P, Clark C. Bile duct surgery in the treatment of hepatobiliary and gallbladder malignancies: effects of hepatic and vascular resection on outcomes. HPB (Oxford). 2015;17(12):1066-1073.

Allen S, DeRoche A, Adams L, Slocum K, Fitzgerald N, Clark CJ, Shen P. Effect of epidural compared to patient-controlled intravenous analgesia on outcomes for patients undergoing hepatectomy [abstract]. Ann Surg Oncol. 2015;22(Suppl 1):S102.

Mogal HD, Levine EA, Fino NF, Obiora C, Shen P, Stewart JH, Votanopoulos KI. Routine admission to intensive care unit after cytoreductive surgery and heated intraperitoneal chemotherapy: not always a requirement. Ann Surg Oncol. 2015;():.

Levine EA, Stewart JH IV, Shen P, Russell GB, Loggie BL, Votanopoulos KI. Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients. J Am Coll Surg. 2014;218(4):573-585.

Votanopoulos KI, Randle RW, Craven B, Swett KR, Levine EA, Shen P, Stewart JH, Mirzazadeh M. Significance of urinary tract involvement in patients treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2014;21(3):868-874.

Randle RW, Swett KR, Swords DS, Shen P, Stewart JH, Levine EA, Votanopoulos KI. Efficacy of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the management of malignant ascites. Ann Surg Oncol. 2014;21(5):1474-1479.

Trottman P, Swett K, Shen P, Sirintrapun J. Comparison of standard distal pancreatectomy and splenectomy with radical antegrade modular pancreatosplenectomy. Am Surg. 2014;80(3):295-300.

Blackham AU, Swett K, Eng C, Sirintrapun J, Bergman S, Geisinger KR, Votanopoulos K, Stewart JH, Shen P, Levine EA. Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2014;109(7):740-745.

Ahmed S, Levine EA, Swett KR, Randle RW, Shen PW, Stewart JH, Votanopoulos KI. Significance of diaphragmatic resections and thoracic chemoperfusion on outcomes of peritoneal surface disease treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) [abstract]. Ann Surg Oncol. 2014;21(Suppl 1):S135.

Randle RW, Swett KR, Stewart JH, Shen P, Levine EA, Votanopoulos KI. Morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with diabetes [abstract]. Ann Surg Oncol. 2014;21(Suppl 1):S87.

Turaga K, Levine E, Barone R, Sticca R, Petrelli N, Lambert L, Nash G, Morse M, Adbel-Misih R, Alexander HR, Attiyeh F, Bartlett D, Bastidas A, Blazer T, Chu Q, Chung K, Dominguez-Parra L, Espat NJ, Foster J, Fournier K, Garcia R, Goodman M,. Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States. Ann Surg Oncol. 2014;21(5):1501-1505.

Sirintrapun SJ, Blackham AU, Russell G, Votanopoulos K, Stewart JH, Shen P, Levine EA, Geisinger KR, Bergman S. Significance of signet ring cells in high-grade mucinous adenocarcinoma of the peritoneum from appendiceal origin. Hum Pathol. 2014;45(8):1597-1604.

Blackham AU, Russell GB, Stewart JH IV, Votanopoulos K, Levine EA, Shen P. Metastatic colorectal cancer: survival comparison of hepatic resection versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2014;21(8):2667-2674.

Shen P, Thomas CR, Fenstermaker J, Aklilu M, McCoy TP, Levine EA. Phase II trial of adjuvant oral thalidomide following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface disease from colorectal/appendiceal cancer. J Gastrointest Cancer. 2014;45(3):268-275.

Ahmed S, Levine EA, Randle RW, Swett KR, Shen P, Stewart JH, Votanopoulos KI. Significance of diaphragmatic resections and thoracic chemoperfusion on outcomes of peritoneal surface disease treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2014;21(13):4226-4231.

Randle RW, Levine EA, Clark CJ, Stewart JH, Shen P, Votanopoulos KI. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for gallbladder cancer: a retrospective review. Am Surg. 2014;80(7):710-713.

Ahmed S, Shen P, Clark CJ.. Spigelain hernia with gallstone ileus: what are the chances?. Am Surg. 2014;80(8):E227-E229.

Caserta MP, Sakala M, Shen P, Gorden L, Wile G. Presurgical planning for hepatobiliary malignancies: clinical and imaging considerations. Magn Reson Imaging Clin N Am. 2014;22(3):447-465.

Ahmed S, Stewart JH, Shen P, Votanopoulos KI, Levine EA. Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis. J Surg Oncol. 2014;110(5):575-584.

Bryan ML, Fitzgerald NC, Levine EA, Shen P, Stewart JH, Votanopoulos KI. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in sarcomatosis from gastrointestinal stromal tumor. Am Surg. 2014;80(9):890-895.

Allen BC, Shen P. Peritoneal carcinomatosis: radiologic diagnosis In: Esquivel J, ed. Advances in the management of peritoneal carcinomatosis. London England: Unitec House;2014: 16-30.

Votanopoulos K, Ihemelandu C, Shen P, Stewart J, Russell G, Levine EA. A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C. J Surg Res. 2013;179(1):e133-e139.

Addington E, Russell G, Tedeschi R, Levine E, Shen P, Stewart J, Danhauer S, Duckworth K, McQuellon R. Post-traumatic growth is sustained two years after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy [abstract]. Psychooncology. 2013;22(Suppl 2):54.

Sirintrapun J, Blackham A, Russell G, Stewart J, Shen P, Levine E, Geisinger K, Bergman S, Cimic A. Significance of signet-ring cells in extracellular mucin pools versus tissue in high-grade mucinous carcinoma peritonei [abstract]. Lab Invest. 2013;93(Suppl 1):180A.

Votanopoulos KI, Swett K, Blackham AU, Ihemelandu C, Shen P, Stewart JH, Levine EA. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from rectal cancer. Ann Surg Oncol. 2013;20(4):1088-1092.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, General Surgery

Clinical Interests

Gastrointestinal Oncology Surgery, Hepatobiliary Surgery, Melanoma, Minimally Invasive Liver and Pancreatic Resection, Pancreatic Surgery, Peritoneal Surface Malignancies, Sarcoma
Perry Shen, M.D.

Perry Shen, M.D.

Program Director, Surgical Oncology
Professor, General Surgery
Comprehensive Cancer Center

Doctor Rating

4.7 out of 5

Perry Shen, M.D.190 Ratings
18 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.8
CP efforts to include in decisions
4.8
CP explanations of prob/condition
4.8
CP spoke using clear language
4.8
Friendliness/courtesy of CP
4.8
Likelihood of recommending CP
4.8
Patients' confidence in CP
4.9
Time CP spent with patient
4.7
Wait time at clinic
3.7



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

3/28/2016

Doctor seemed to care about my situation and wants to do what is best for me.

3/22/2016

Great.

1/6/2016

Good.

1/1/2016

Dr. Shen is a great dotor

12/31/2015

I love Dr. Shen

12/20/2015

Dr. Shen sat down with us and took time to explain my medical condition and surgery needed. He was very through explaining the surgery options. He answered all our questions, concerns in detail and we left knowing what to expect. We are very thankful for Dr. Shen's decision to remove the tumor rather than just a biopsy and the positive outcome from the surgery.

12/15/2015

I am trusting Dr. Shen with my level 4 cancer. He is going to do a HIPEC procedure -- only choice to save my life. He and I are going for another 10 years of productive life.

11/17/2015

always willing to answer all ques

11/2/2015

Dr Shen was very caring and thorough

10/28/2015

communication seem to be poor between my local doctor and wakeforest

10/27/2015

Dr Shen is certainly qualified and I have full confidence in him.

9/25/2015

I have recommended *Dr. Shen to several people & they have come to the hospital.

9/4/2015

Would recommend *Dr. Shen and his staff to anyone they are awesome.

8/25/2015

*Dr. Shen is an awesome surgeon. He has done surgery on me twice & I did excellent post surgery both times.

7/21/2015

*Dr. Shen always is through and explains everything in terms I can understand.

7/14/2015

Great doctor - could not have gotten better care.

6/15/2015

Dr. Shen is a treasure. He is dedicated to providing the best care possible for his patients. I am tremendously grateful to him and his terrific team.

5/21/2015

I have been a patient of Dr. Shen's for 7 years now. He has been wonderful to me and my family and I have all the confidence in the world in him. He has saved my life.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2015-2016Magnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.